FDA Approves First Generic Ondansetron Tablets, Orally Disintegrating Tablets And Oral Solution
Thu, 04 Jan 2007 01:00 PM EST
... The Food and Drug Administration today approved the first generic versions of Zofran (Ondansetron) Tablets, Orally Disintegrating Tablets and Oral Solution which are indicated to prevent nausea and vomiting associated with surgery, radiotherapy and cancer chemotherapy. The approval is an important step in the agency's effort to increase the availability of lower-cost generic medications. [click link for full article] ...
Related Topics
- Ondansetron
- Rizatriptan Disintegrating Tablets
- Clonazepam Orally Disintegrating Tablets
- Carbinoxamine and Pseudoephedrine Tablets
- Baclofen Disintegrating Tablets
- Clozapine Orally-Disentegrating Tablets
- Carbinoxamine and Pseudoephedrine Extended-Release Tablets
- Ondansetron Oral Solution
- Olanzapine Disintegrating Tablets
- Cyanocobalamin Tablets
- Isosorbide Dinitrate, Tablets or Extended-Release Tablets or Capsules
- Chlorpheniramine, Pseudoephedrine and Hydrocodone Tablets
- Guaifenesin and Dextromethorphan
- Neostigmine Tablets
- Haloperidol Tablets
- Thiabendazole Tablets
- Carbetapentane, Phenylephrine, and Pyrilamine
- Desloratadine Disintegrating Tablets
- Lansoprazole Disintegrating Tablets
- Ergoloid Mesylates Sublingual Tablets

Not Signed In -

